ScoreWhy is Supriya Lifescience Ltd ?
1
High Management Efficiency with a high ROE of 17.74%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 11.47% and Operating profit at 5.52% over the last 5 years
4
Flat results in Dec 25
5
With ROE of 18.6, it has a Expensive valuation with a 5.4 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -0.77%, its profits have risen by 6.4% ; the PEG ratio of the company is 4.6
6
Majority shareholders : Promoters
7
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 11.96% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -0.77% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Supriya Lifesci. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Supriya Lifesci. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Supriya Lifesci.
-0.77%
-0.02
37.79%
Sensex
9.35%
0.80
11.65%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.47%
EBIT Growth (5y)
5.52%
EBIT to Interest (avg)
81.39
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.70
Tax Ratio
24.90%
Dividend Payout Ratio
4.28%
Pledged Shares
0
Institutional Holding
10.21%
ROCE (avg)
28.52%
ROE (avg)
17.74%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
32
Price to Book Value
5.44
EV to EBIT
22.49
EV to EBITDA
20.28
EV to Capital Employed
5.80
EV to Sales
7.28
PEG Ratio
4.59
Dividend Yield
0.15%
ROCE (Latest)
26.04%
ROE (Latest)
18.62%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
NET SALES(Q)
Highest at Rs 206.44 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Supriya Lifesci.
Net Sales - Quarterly
Highest at Rs 206.44 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
